Cyclooxygenase-2 Inhibitor NS398 Enhances Antitumor Effect of Irradiation on Hormone Refractory Human Prostate Carcinoma Cells
- 1 November 2003
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 170 (5) , 2036-2039
- https://doi.org/10.1097/01.ju.0000092239.98832.52
Abstract
Purpose: We examined the potential therapeutic effect of NS398, a selective cyclooxygenase-2 (COX-2) inhibitor, combined with irradiation on human prostate adenocarcinoma DU145 cells.Materi...Keywords
This publication has 13 references indexed in Scilit:
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in the human prostateUrology, 2000
- INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVOJournal of Urology, 2000
- The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2Journal of Biological Chemistry, 2000
- Over-expression of cyclooxygenase-2 in human prostate adenocarcinomaThe Prostate, 1999
- COX-2 inhibitors for colorectal cancerNature Medicine, 1998
- A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results programCancer, 1997
- Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potentialProceedings of the National Academy of Sciences, 1997
- Routine prostate biopsies following radiotherapy for prostate cancer: Results for 226 patientsUrology, 1995
- Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective StudyEpidemiology, 1994